Nkarta, Inc. – NASDAQ:NKTX

Nkarta stock price today

$2.34
-0.07
-2.9%
Financial Health
0
1
2
3
4
5
6
7
8
9

Nkarta stock price monthly change

-62.98%
month

Nkarta stock price quarterly change

-62.98%
quarter

Nkarta stock price yearly change

-55.12%
year

Nkarta key metrics

Market Cap
162.66M
Enterprise value
228.56M
P/E
-1.52
EV/Sales
N/A
EV/EBITDA
-2.16
Price/Sales
N/A
Price/Book
0.49
PEG ratio
N/A
EPS
-2.35
Revenue
N/A
EBITDA
-124.75M
Income
-116.20M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Nkarta stock price history

Nkarta stock forecast

Nkarta financial statements

Nkarta, Inc. (NASDAQ:NKTX): Profit margin
Jun 2023 0 -33.28M
Sep 2023 0 -25.64M
Dec 2023 10.54M -27.75M -263.27%
Mar 2024 0 -29.51M
Nkarta, Inc. (NASDAQ:NKTX): Analyst Estimates
Sep 2025 0 -27.81M
Oct 2025 0 -27.19M
Dec 2025 0 -34.34M
Dec 2025 0 -27.36M
  • Analysts Price target

  • Financials & Ratios estimates

Nkarta, Inc. (NASDAQ:NKTX): Debt to assets
Jun 2023 429038000 111.06M 25.89%
Sep 2023 405864000 109.04M 26.87%
Dec 2023 378885000 105.6M 27.87%
Mar 2024 576936000 103.28M 17.9%
Nkarta, Inc. (NASDAQ:NKTX): Cash Flow
Jun 2023 -21.77M -3.17M 395K
Sep 2023 -20.27M 29.42M 0
Dec 2023 -23.35M 15.83M 295K
Mar 2024 -28.50M 21.48M 226.26M

Nkarta alternative data

Nkarta, Inc. (NASDAQ:NKTX): Employee count
Aug 2023 165
Sep 2023 169
Oct 2023 169
Nov 2023 169
Dec 2023 167
Jan 2024 167
Feb 2024 167
Mar 2024 150
Apr 2024 150
May 2024 150
Jun 2024 150
Jul 2024 150

Nkarta other data

26.56% -59.90%
of NKTX is owned by hedge funds
11.59M -30.45M
shares is hold by hedge funds

Nkarta, Inc. (NASDAQ:NKTX): Insider trades (number of shares)
Period Buy Sel
Jun 2023 0 4030
Aug 2023 0 1331
Jan 2024 0 24875
Feb 2024 0 4143
Mar 2024 8000031 8367
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
RA CAPITAL MANAGEMENT, L.P. director, 10 percent owner:
Common Stock 3,000,000 $10 $30,000,000
Purchase
RA CAPITAL MANAGEMENT, L.P. director, 10 percent owner:
Pre- Funded Warrants (Right to Buy) 3,000,031 N/A N/A
Purchase
GEORGE SIMEON director
Common Stock 1,548,341 $10 $15,483,410
Purchase
GEORGE SIMEON director
Common Stock 451,659 $10 $4,516,590
Option
BRANDENBERGER RALPH officer: Chief Technical Officer
Common Stock 2,955 $3.89 $11,495
Option
BRANDENBERGER RALPH officer: Chief Technical Officer
Common Stock 3,808 $3.89 $14,813
Sale
BRANDENBERGER RALPH officer: Chief Technical Officer
Common Stock 8,367 $12.51 $104,671
Option
BRANDENBERGER RALPH officer: Chief Technical Officer
Stock Option (right to buy) 2,955 $3.89 $11,495
Option
BRANDENBERGER RALPH officer: Chief Technical Officer
Stock Option (right to buy) 3,808 $3.89 $14,813
Sale
TRAGER JAMES officer: Chief Scientific Officer
Common Stock 4,143 $12 $49,716
Patent
Application
Filling date: 7 Jan 2022 Issue date: 28 Jul 2022
Grant
Filling date: 27 Mar 2018 Issue date: 21 Jun 2022
Grant
Filling date: 4 Nov 2020 Issue date: 22 Feb 2022
Application
Filling date: 22 Nov 2019 Issue date: 17 Feb 2022
Application
Filling date: 10 Jun 2021 Issue date: 6 Jan 2022
Application
Filling date: 11 Sep 2019 Issue date: 4 Nov 2021
Grant
Filling date: 4 Nov 2020 Issue date: 26 Oct 2021
Grant
Filling date: 4 Nov 2020 Issue date: 12 Oct 2021
Application
Filling date: 4 Nov 2020 Issue date: 11 Mar 2021
Application
Filling date: 4 Nov 2020 Issue date: 11 Mar 2021
Thursday, 5 December 2024
globenewswire.com
Tuesday, 26 November 2024
globenewswire.com
Tuesday, 12 November 2024
globenewswire.com
Thursday, 7 November 2024
globenewswire.com
Tuesday, 8 October 2024
benzinga.com
Tuesday, 3 September 2024
globenewswire.com
Wednesday, 14 August 2024
fool.com
Tuesday, 13 August 2024
globenewswire.com
globenewswire.com
Tuesday, 16 July 2024
globenewswire.com
Wednesday, 10 July 2024
zacks.com
Monday, 1 July 2024
investorplace.com
Thursday, 27 June 2024
globenewswire.com
Thursday, 13 June 2024
globenewswire.com
Saturday, 25 May 2024
seekingalpha.com
Thursday, 9 May 2024
globenewswire.com
Tuesday, 7 May 2024
investorplace.com
Saturday, 27 April 2024
Seeking Alpha
Wednesday, 3 April 2024
GlobeNewsWire
Sunday, 31 March 2024
24/7 Wall Street
Thursday, 29 February 2024
InvestorPlace
Wednesday, 28 February 2024
GlobeNewsWire
Tuesday, 20 February 2024
InvestorPlace
Thursday, 8 February 2024
InvestorPlace
Tuesday, 6 February 2024
InvestorPlace
Monday, 5 February 2024
InvestorPlace
Sunday, 4 February 2024
InvestorPlace
Tuesday, 19 December 2023
PennyStocks
Friday, 8 December 2023
Zacks Investment Research
Tuesday, 7 November 2023
GlobeNewsWire
  • What's the price of Nkarta stock today?

    One share of Nkarta stock can currently be purchased for approximately $2.34.

  • When is Nkarta's next earnings date?

    Unfortunately, Nkarta's (NKTX) next earnings date is currently unknown.

  • Does Nkarta pay dividends?

    No, Nkarta does not pay dividends.

  • How much money does Nkarta make?

    Nkarta has a market capitalization of 162.66M.

  • What is Nkarta's stock symbol?

    Nkarta, Inc. is traded on the NASDAQ under the ticker symbol "NKTX".

  • What is Nkarta's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Nkarta?

    Shares of Nkarta can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Nkarta's key executives?

    Nkarta's management team includes the following people:

    • Mr. Paul J. Hastings Chief Executive Officer, Pres & Director(age: 65, pay: $820,100)
    • Dr. Nadir Mahmood Ph.D. Chief Financial & Bus. Officer(age: 46, pay: $479,180)
    • Dr. Alicia J. Hager Chief Legal Officer & Corporation Sec.(age: 55, pay: $420,630)
  • How many employees does Nkarta have?

    As Jul 2024, Nkarta employs 150 workers.

  • When Nkarta went public?

    Nkarta, Inc. is publicly traded company for more then 5 years since IPO on 10 Jul 2020.

  • What is Nkarta's official website?

    The official website for Nkarta is nkartatx.com.

  • Where are Nkarta's headquarters?

    Nkarta is headquartered at 6000 Shoreline Court, South San Francisco, CA.

  • How can i contact Nkarta?

    Nkarta's mailing address is 6000 Shoreline Court, South San Francisco, CA and company can be reached via phone at +41 55824923.

Nkarta company profile:

Nkarta, Inc.

nkartatx.com
Exchange:

NASDAQ

Full time employees:

159

Industry:

Biotechnology

Sector:

Healthcare

Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the surface of tumor cells. Its two co-lead product candidates are NKX101, which is in Phase I clinical trials for the treatment of relapsed/refractory acute myeloid leukemia or higher risk myelodysplastic syndromes; and NKX019, a pre-clinical product, which is based on the ability to treat various B cell malignancies by targeting the CD19 antigen found on these types of cancerous cells. The company has a research collaboration agreement with CRISPR Therapeutics AG. Nkarta, Inc. was incorporated in 2015 and is based in South San Francisco, California.

6000 Shoreline Court
South San Francisco, CA 94080

CIK: 0001787400
ISIN: US65487U1088
CUSIP: 65487U108